Furthermore, HMGB1 can be released into the extracellular environment, where it acts as a DAMP molecule, contributing to pro-inflammatory immune responses and disease progression in conditions such as systemic lupus erythematosus and rheumatoid arthritis [57–63]. Here, HMGB1 is linked to rheumatoid arthritis.